Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001193125-25-323885
Filing Date
2025-12-18
Accepted
2025-12-18 10:06:27
Documents
1
Effectiveness Date
2025-12-18
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9503
  Complete submission text file 0001193125-25-323885.txt   10877
Mailing Address BIOCITY GLASGOW BO'NESS ROAD, NEWHOUSE LANARKSHIRE X0 ML1 5UH
Business Address BIOCITY GLASGOW BO'NESS ROAD, NEWHOUSE LANARKSHIRE X0 ML1 5UH 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: D | Act: 33 | File No.: 021-567275 | Film No.: 251581607
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)